Particle.news
Download on the App Store

Agilon Health Investors Reminded of March 2 Lead-Plaintiff Deadline in Securities Case

Fresh notices urge investors to seek leadership roles over allegations of misleading 2025 guidance.

Overview

  • Rosen Law Firm and Levi & Korsinsky issued new reminders to agilon health, inc. shareholders about the securities class action covering purchases between February 26, 2025 and August 4, 2025.
  • Investors seeking to serve as lead plaintiff must move the court by March 2, 2026, with Rosen stating it first filed the case.
  • The complaints allege agilon recklessly issued 2025 guidance that was not achievable and overstated the immediate benefits of risk-reduction 'strategic actions.'
  • Rosen notes that no class has been certified and that investors are not represented by counsel unless they retain one.
  • Kuehn Law separately announced an investigation into potential fiduciary-duty issues involving certain agilon officers and directors.